Photocatalytic degradation of imidacloprid using Ag2O/CuO composites.

Imidacloprid is one of the most commonly used neonicotinoid pesticides that has been identified as a neurotoxin for various non-target organisms. It binds to the central nervous system of organisms, causing paralysis and eventually death. Thus, it is imperative to treat waterwaters contaminated with imidacloprid using an efficient and cost effective method. The present study presents Ag2O/CuO composites as excellent catalysts for the photocatalytic degradation of imidacloprid. The Ag2O/CuO composites were prepared in different compositions by adopting the co-precipitation method and used as a catalyst for the degradation of imidacloprid. The degradation process was monitored using UV-vis spectroscopy. The composition, structure, and morphologies of the composites were determined by FT-IR, XRD, TGA, and SEM analyses. The effect of different parameters i.e time, concentration of pesticide, concentration of catalyst, pH, and temperature on the degradation was studied under UV irradiation and dark conditions. The results of the study evidenced the 92.3% degradation of imidacloprid in only 180 minutes, which was 19.25 hours under natural conditions. The degradation followed first-order kinetics, with the half life of the pesticide being 3.7 hours. Thus, the Ag2O/CuO composite was an excellent cost-effective catalyst. The non-toxic nature of the material adds further benefits to its use. The stability of the catalyst and its reusability for consecutive cycles make it more cost effective. The use of this material may help to ensure an immidacloprid free environment with minimal use of resources. Moreover, the potential of this material to degrade other environmental pollutants may also be explored.

A triclinic polymorph of N-[4-(4-methyl-benzene-sulfonamido)-phenyl-sulfon-yl]acetamide.

In the asymmetric unit of the title compound, C(15)H(16)N(2)O(5)S(2), there are two symmetry-independent mol-ecules which adopt similar conformations, with dihedral angles between the aromatic rings of 59.30 (8) and 61.81 (8)°, and dihedral angles between acetamide group and the benzene ring of 77.08 (10) and 78.40 (10)°. Each type of mol-ecule forms similar one-dimensional polymeric structures extending along the b axis via N-H⋯O hydrogen bonds. These hydrogen bonds generate two types of centrosymmetric motifs, R(2) (2)(8) and R(2) (2)(20). Moreover C-H⋯O inter-actions assemble the mol-ecules into a three-dimensional framework. The crystal structure was determined from a non-merohedral twin [ratio of the twin components = 0.322 (4):0.678 (4)].

Increasing peak expiratory flow time in amyotrophic lateral sclerosis.

BACKGROUND: Serial measurements of pulmonary function to indicate decreasing respiratory muscle strength in patients with amyotrophic lateral sclerosis (ALS) is well documented. Quantitative outcome measures include declining FVC, FEV1, maximal inspired pressure, maximal expired pressure, and maximal voluntary ventilation. Increasing peak expiratory flow time (PEFT) may represent a further sensitive measure of declining respiratory muscle strength in ALS. METHODS: Fifty-five patients with ALS performed flow-volume loops serially after presentation. The percentage change from baseline values for FVC, peak expiratory flow (PEFR), and PEFT were compared using Spearman correlation coefficients. The prolongation of PEFT with serial tests was analyzed using a Kruskal-Wallis with a Dunn multiple comparison test. Bulbar-onset and limb-onset PEFT was compared using the Mann-Whitney test. RESULTS: PEFT was significantly increased from baseline values at all follow-up tests. However, PEFTs measured at the third, fourth, fifth, and sixth visits, although higher, were not significantly different. Significant negative correlations existed between the increase in PEFT and the decrease in PEFR and FVC. Significant positive correlations existed between the increase in PEFT and days from diagnosis and the decrease in PEFR and decrease in FVC. CONCLUSION: PEFT increases significantly and linearly with time in patients with ALS and may begin to plateau with bulbar symptoms. PEFT increases at a faster rate than the rate of decline in both FVC and PEFR. PEFT is a quantitative measure of decreasing pulmonary function in ALS that is easily measured.

Advantages of the intrabreath technique as a measure of lung function before and after heart transplantation.

BACKGROUND: Pulmonary function testing is an integral part of evaluating patients who are being considered for cardiac transplantation. The accurate measurement of diffusing capacity (DLCO) and alveolar volume (VA) is dependent on a 10-s breath-holding maneuver that may be difficult for patients with congestive heart failure to perform. The intrabreath (IB) technique is not dependent on a breath-holding maneuver and may provide more accurate pulmonary function testing results in chronically debilitated patients. METHODS: Seventy-five patients performed maneuvers with IB and single-breath (SB) techniques during evaluation for heart transplantation and at 3 and 12 months following transplantation. The DLCO, VA, and total lung capacity (TLC) were compared using Pearson correlation coefficients, a Student t test, and intercorrelation coefficients. RESULTS: The DLCO and VA, when determined with the IB technique, had excellent correlations to the SB technique over all ranges of DLCO values. VA values that were determined by the IB technique were greater than those determined by the SB technique and more closely approximated the TLC values. The satisfactory correlation between the two techniques was maintained when DLCO was corrected for VA. However, due to the lower values for VA as determined by the SB method, the corrected measurements were consistently higher for the SB technique. CONCLUSION: Pulmonary function can be measured accurately in a population of patients with long-standing congestive heart failure, both before and after cardiac transplantation, using the IB technique. Furthermore, the IB technique may provide a more accurate measurement of VA.